Stock FRTX FRESH TRACKS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Fresh Tracks Therapeutics, Inc.

Equities

FRTX

US10802T2042

Market Closed - OTC Markets
Other stock markets
 18:51:21 29/04/2024 BST 		5-day change 1st Jan Change
0.9102 USD +0.01% Intraday chart for Fresh Tracks Therapeutics, Inc. +0.02% +3.54%
03-15 Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index CI

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Fresh Tracks Therapeutics : Termination of Material Agreement - Form 8-K
PU
Fresh Tracks Therapeutics Urges Stockholders to Vote at the Upcoming Special Meeting on February 15th
AQ
Fresh Tracks Therapeutics Announces Plan to Hold New Special Meeting of Stockholders on February 15th
AQ
Fresh Tracks Therapeutics Announces Listing on OTC Pink Market
AQ
Fresh Tracks Therapeutics Announces its Common Stock will be Suspended from Trading on Nasdaq at Open of Business on December 19th
AQ
Fresh Tracks Therapeutics : Termination of Material Agreement - Form 8-K
PU
Fresh Tracks Therapeutics Announces Third Adjournment of Special Meeting of Stockholders
AQ
Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders
AQ
Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders
AQ
Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders
AQ
Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders
AQ
Fresh Tracks Therapeutics: Q3 Earnings Snapshot
AQ
Fresh Tracks Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
AQ
Fresh Tracks Therapeutics Announces Board Approval of Plan of Liquidation and Dissolution
AQ
Fresh Tracks Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
AQ
Fresh Tracks Therapeutics: Q2 Earnings Snapshot
AQ
Fresh Tracks Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
AQ
Fresh Tracks Announces $8.25 Million Buyout of Its Right to Receive Future Sofpironium Bromide Payments from Botanix
AQ
CapitalGainsReport Penny Stock Bounce List: EPAZ, ARDS, FRTX, GNPX
AQ
Fresh Tracks Announces $8.25 Million Buyout of Its Right to Receive Future Sofpironium Bromide Payments from Botanix
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. FRTX Stock
  4. News Fresh Tracks Therapeutics, Inc.
  5. Press Releases